BrightGene Bio-Medical Technology surges to daily limit on news of mass producing Remdesivir

Shares of China's tech board listed BrightGene Bio-Medical Technology (688166.SH) surges to the daily limit (20%) the moment the market opens Wednesday morning.

The company announced yesterday it is mass producing generic drug of anti-virus Remdesivir.

Editor: Tan Yuhan